Viking Therapeutics (NASDAQ:VKTX), a clinical-stage biopharmaceutical company, is making significant strides in the development of a weight-loss drug that could shake up the highly competitive obesity ...
Taking a diabetes medication to lower your risk of dementia seems like a big leap, but people with the condition are already at a higher risk of developing it. Here’s what you need to know about the ...
In a small minority of people, obesity is caused by genetic variants. When this is the case, new treatments can sometimes be found to benefit these people – and we’re now hoping to run a clinical ...